My goal is to provide compassionate cancer care. I understand that getting diagnosed with cancer can be a source of worry and uncertainty. With our collaborative approach, I will guide you through your treatment journey and will be with you every step of the way. I understand that every individual is unique. For this reason, I go to great lengths to personalize your treatment. I make sure that we consider your values and goals while remaining attentive to the characteristics of your specific cancer. By the end of our initial consultation, my aim is to ensure that all your questions and concerns have been addressed, and that you have a good understanding of the overall treatment plan. In treating cancer, we use state of the art technology and work closely with other specialists to design the best treatment plan.

Virag Dandekar, MD
Radiation Oncology
Practices In:
Joliet
Patients Seen:
Adults
Board Certifications
Radiation Oncology
Languages
English
Awards & Accolades
2017 Finalist for Physician of the Year - AMITA Saint Joseph Medical Center
2017
Clinical Interests
I have a special interest in radiosurgery and stereotactic body radiotherapy. This technology allows us to treat patients non-invasively in as few as one to five treatments.
Personal Interests
In my free time, I enjoy traveling with my wife, scuba diving, photography, reading and watching sports.
Memberships
American Society for Therapeutic Radiation Oncology
AMITA Health Presence Saint Joseph Hospital, Joliet
Morris Hospital & Healthcare Centers
School
University of Illinois at Chicago
Graduation Date:
2009
Degree:
MD
Residency
Rush University Medical Center
Resident in Radiation Oncology
Provider’s Publications
Liao Y, Dandekar V, Chu, JC, Turian J, Bernard D, Kiel K. Reporting small bowel dose in cervix cancer high-dose-rate brachytherapy. Med Dosim.
Spring 2016
Dandekar V, Young J, Kiel K, Bonomi P, Fidler MJ, Batus, Marta, Sher DJ. Efficacy and tolerability of palliative split-course thoracic chemoradiotherapy for symptomatic non-small cell lung cancer. Am J Clin Oncol.
December 2015
Dandekar V, Morgan T, Turian J, Fidler MJ, Showel J, Nielsen T, Coleman J, Diaz A, Sher DJ. Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing. Oral Oncol.
May 2014
Dandekar V, Abrams RAA, Kent PM. Radiation therapy in primary bone tumors for young patients. Current Problems in Cancer.
July-Aug 2013
Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys.
March 2011
Mell LK, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR. Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol.
January 2010
Procedures
Accelerated Fractionation Radiation, Brachytherapy, High-Dose Rate (HDR), Image Guided Radiation Therapy (IGRT), Intensity Modulated Radiation Therapy (IMRT), RapidArc® Radiotherapy, Respiratory Gating, Stereotactic Body Radiation Therapy (SBRT), Stereotactic Radiosurgery (SRS), Stereotactic Radiotherapy (SRT)
Conditions
Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer, Gynecologic Cancers, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Skin Cancer
Comments